Patent laws in India and its impact on Pharmaceutical Industry. Int J Pharma Bio Sci V1(2) 2010.Puranik S.B, et al, Patent laws in India and its impact on pharmaceutical industry, International journal of pharma and biosciences,2010; 1(2): 1- 17....
In effect, this amounted to giving the public (even more so the patients) the right to oppose granting of patents without incurring cost to their objection.These provisions were put to test in a famous case between Novartis (Glivec) and the government of India specifically on Section 3(d)....
Patent laws are enacted to stimulate innovation and invention, which ultimately leads to the benefit of the public at large. They are the negative rights that are granted not only for the personal benefits of the patentee but for the public interest, whi
As India continues to refine its patent laws and practices, stakeholders can expect further improvements in the legal and regulatory framework. These developments, coupled with India’s growing emphasis on innovation and technology, position the country as an increasingly attractive destination for patent...
The panel will review recent case law and USPTO guidance on Section 101 patent eligibility and offer strategies to address Section 101 rejections. Read More Protecting Software as a Medical Device: Patents, Design Patents, and Trade Secrets October 1, 2024 • CLE • CLE On-Demand, ...
Patent: IP boutique Obhan & Associates is recommended for patent protection and disputes work. Managing partner Essenese Obhan and partner Aparna Kareer are the key individuals for patents. In a precedent-setting case that featured India’s leading patent lawyers. ...
When all the requirements of the FER are met or in case of opposition under section 25(1),if the opposition is decided in favour of the applicant ,the patent is granted, after 6 months from the date of publication under section 11 A, the letter patent is issued, entry is made in the...
Sans Frontières (MSF) argues that the case should be rejected because it concerns a tweak to an existing formulation of the drug—a technique known as “evergreening”—and does not represent an improvement in clinical effectiveness, as required under section 3(d) of India’s patent laws. ...
As per the Indian Patent Act, Sections 3 and 4, the following inventions are not considered patentable in India: An invention that is considered frivolous or trivial An invention that claims anything which is obviously against well-established natural laws The mere discovery of a scientific pri...
v) Address for service in India; vi) Power of attorney in case apatent agentis appointed; vii) Certified copy of the translation. A valid certificate from a translator is needed in case the priority application is non-English; viii) Furnishing, where applicable, of a nucleotide and/or amino...